3-121790112-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001023570.4(IQCB1):βc.1090C>Tβ(p.Arg364*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000328 in 1,613,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001023570.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IQCB1 | NM_001023570.4 | c.1090C>T | p.Arg364* | stop_gained | 11/15 | ENST00000310864.11 | NP_001018864.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IQCB1 | ENST00000310864.11 | c.1090C>T | p.Arg364* | stop_gained | 11/15 | 1 | NM_001023570.4 | ENSP00000311505.6 | ||
IQCB1 | ENST00000349820.10 | c.691C>T | p.Arg231* | stop_gained | 8/12 | 1 | ENSP00000323756.7 | |||
IQCB1 | ENST00000393650.7 | n.*68C>T | non_coding_transcript_exon_variant | 10/14 | 5 | ENSP00000377261.3 | ||||
IQCB1 | ENST00000393650.7 | n.*68C>T | 3_prime_UTR_variant | 10/14 | 5 | ENSP00000377261.3 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152072Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251366Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135856
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461366Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 727032
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152072Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74306
ClinVar
Submissions by phenotype
Senior-Loken syndrome 5 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.008%). The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000167197 / PMID: 19430481 / 3billion dataset). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 08, 2024 | - - |
Nephronophthisis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2023 | This sequence change creates a premature translational stop signal (p.Arg364*) in the IQCB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IQCB1 are known to be pathogenic (PMID: 15723066, 21901789, 23559409, 28041643). This variant is present in population databases (rs727503968, gnomAD 0.1%). This premature translational stop signal has been observed in individuals with Senior-Lββken syndrome and Leber congenital amaurosis (PMID: 19430481, 23661368, 24674142, 26274329). ClinVar contains an entry for this variant (Variation ID: 167197). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 05, 2014 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at